Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Board game beats boredom: new study tests fun way to tackle diabetes anxiety

NCT ID NCT07195188

Symptom relief Sponsor: Izmir Tinaztepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether playing a board game called 'Let's Learn Diabetes' could lower anxiety and help people with type 2 diabetes better follow their insulin treatment. 72 adults aged 40-65 who recently started insulin were randomly assigned to either four weekly game sessions or standard education. Researchers measured anxiety and treatment adherence before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Let's Learn Diabetes board game education program
What this could lead to
If it works, this could offer a fun, low-cost way to help people with diabetes feel less anxious and stick to their insulin treatment.
What could go wrong
This is a small, completed trial with only 72 participants, so results may not apply to everyone. The effect may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Apr 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

nclusion Criteria: Age at diagnosis of diabetes is at least 1 year. The maximum duration of insulin treatment initiation is 3 months. Not having any mental problems. Between the ages of 40 and 65 years. Volunteering to participate in the study. Exclusion Criteria: Age at diagnosis of diabetes is recent or less than 1 year. Being on insulin therapy for more than three months. Mental or psychological comorbidity. Not within the target age range, under 40 years or over 65 years. Refusing to participate in the research. Not attending one or more of the four training sessions during the research process.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder diabetes mellitus Treatment Adherence and Compliance type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete mellitus Type 2 diabetes

Contacts and locations

Locations

  • Uşak Eğitim Ve Araştırma Hastanesi

    Uşak, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.